Literature DB >> 6862519

Induction of syngeneic tumour-specific immunity by liposomes reconstituted with L2C tumour-cell antigens.

A J Schroit, M E Key.   

Abstract

Liposomes composed of phosphatidylcholine and phosphatidylserine were reconstituted by detergent dialysis with 3 M K Cl extracts of L2C tumour cells. Liposomes containing L2C antigens were as antigenic as intact tumour cells in the elicitation of delayed-type hypersensitivity responses in strain-2 guinea-pigs previously immunized against L2C tumours. Soluble L2C antigens were devoid of immunoprotective activity, whereas the reconstituted liposomes were capable of protecting animals against up to approximately 100 times the minimal lethal dose of tumour cells. Moreover, the reconstituted liposomes were as antigenic and immunoprotective as viable (irradiated) cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6862519      PMCID: PMC1454301     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  15 in total

1.  Induction of allogeneic cytolytic T lymphocytes by partially purified membrane glycoproteins.

Authors:  L Sherman; S J Burakoff; M F Mescher
Journal:  Cell Immunol       Date:  1980-04       Impact factor: 4.868

2.  Specific tumor immunity induced with soluble materials: restricted range of antigen dose and of challenge tumor load for immunoprotection.

Authors:  N R Pellis; B D Kahan
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

3.  Adjuvant activity of synthetic 6-O-"mycoloyl"-N-acetylmuramyl-L-alanyl-D-isoglutamine and related compounds.

Authors:  I Azuma; K Sugimura; M Yamawaki; M Uemiya; S Kusumoto; S Okada; T Shiba; Y Yamamura
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

4.  Insertion of Ia and H-2 alloantigens into model membranes.

Authors:  D R Littman; S E Cullen; B D Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

5.  Allogeneic cytolysis of reconstituted membrane vesicles.

Authors:  N Hollander; S Q Mehdi; I L Weissman; H M McConnell; J P Kriss
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

6.  Reconstitution of purified detergent-soluble HLA-A and HLA-B antigens into phospholipid vesicles.

Authors:  V H Engelhard; B C Guild; A Helenius; C Terhorst; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

7.  Antitumor immunity in strain 2 guinea pigs immunized with potassium chloride extracts of L2C tumor cells.

Authors:  D P Braun; J C Hengst; M B Mokyr; S Dray
Journal:  J Natl Cancer Inst       Date:  1978-04       Impact factor: 13.506

8.  Salt extraction of soluble HL-A antigens.

Authors:  R A Reisfeld; M A Pellegrino; B D Kahan
Journal:  Science       Date:  1971-06-11       Impact factor: 47.728

9.  Immunoadjuvant activities of synthetic 6-O-acyl-N-acetylmuramyl-L-alanyl-D-isoglutamine with special reference to the effect of its administration with liposomes.

Authors:  S Kotani; F Kinoshita; I Morisaki; T Shimono; T Okunaga; H Takada; M Tsujimoto; Y Watanabe; K Kato; T Shiba; S Kusumoto; S Okada
Journal:  Biken J       Date:  1977-12

10.  Solubilization and partial characterization of a tumor-associated transplantation antigen of the guinea pig L2C leukemia.

Authors:  C P Hu; T G Konen; C Hoes; I Green
Journal:  J Immunol       Date:  1978-05       Impact factor: 5.422

View more
  3 in total

1.  Immunization against experimental murine salmonellosis with liposome-associated O-antigen.

Authors:  J V Desiderio; S G Campbell
Journal:  Infect Immun       Date:  1985-06       Impact factor: 3.441

2.  Reconstituted membranes of tumour cells (proteoliposomes) induce specific protection to murine lymphoma cells.

Authors:  J J Bergers; W Den Otter; J W De Groot; A W De Blois; H F Dullens; P A Steerenberg; D J Crommelin
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

3.  Critical factors for liposome-incorporated tumour-associated antigens to induce protective tumour immunity to SL2 lymphoma cells in mice.

Authors:  J J Bergers; W Den Otter; H F Dullens; J W De Groot; P A Steerenberg; M W Mimpen; D J Crommelin
Journal:  Cancer Immunol Immunother       Date:  1993-09       Impact factor: 6.968

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.